Literature DB >> 25932182

Correlation analysis for follicle-stimulating hormone and C-terminal cross-linked telopetides of type i collagen in menopausal transition women with osteoporosis.

Bing Wang1, Yang Song2, Yan Chen2, En-Sheng Wang2, Dan Zheng2, Fan Qu2, Jian-Hong Zhou2.   

Abstract

The sudden drop in estrogen in post-menopausal women can lead to osteoporosis. About one in three women aged more than 50 years experienced an osteoporotic fracture. The aim of this study is to explore function of follicle-stimulating hormone (FSH) in bone metabolism and osteoporosis in menopausal transition women. 164 cases of women in menopausal transition were included, and which were divided into three groups, including < 40 years group, 40-50 years group and > 50 years group. All of patients must with empty stomach, and 5 ml blood was collected from median cubital vein between second day to ninth day in menstruation period. Examination of FSH and C-terminal cross-linked telopetides of type I collagen (CTx) was performed by using ECLIA assay. The results indicated that CTx levels were distinguished among the different aged group, with the increasing level following with the increased age. FSH level in both of < 40 years and 40-50 years old women were positively correlated with CTx level (P < 0.05). The spearman rank correlation analysis results also showed that there were no significant correlation between CTx level and FSH level in > 50 years old women. There were significant differences for the CTx level between 0-40 mIU/ml group and > 40 40 mIU/ml group in all of the three ages group (P < 0.05). In conclusion, it's clinically significant for the combining examination of FSH and CTx in menopausal transition women, which could observe the bone metabolize changes quickly and sensitively, and prevent or therapy the osteoporosis in a further step.

Entities:  

Keywords:  C-terminal cross-linked telopetides of type I collagen; Follicle-stimulating hormone; menopausal transition; osteoporosis

Year:  2015        PMID: 25932182      PMCID: PMC4402829     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  18 in total

1.  FSH directly regulates bone mass.

Authors:  Li Sun; Yuanzhen Peng; Allison C Sharrow; Jameel Iqbal; Zhiyuan Zhang; Dionysios J Papachristou; Samir Zaidi; Ling-Ling Zhu; Beatrice B Yaroslavskiy; Hang Zhou; Alberta Zallone; M Ram Sairam; T Rajendra Kumar; Wei Bo; Jonathan Braun; Luis Cardoso-Landa; Mitchell B Schaffler; Baljit S Moonga; Harry C Blair; Mone Zaidi
Journal:  Cell       Date:  2006-04-21       Impact factor: 41.582

2.  Vertebral fractures.

Authors:  C Cooper; L J Melton
Journal:  BMJ       Date:  1992-03-28

3.  Relationship of age-related concentrations of serum FSH and LH with bone mineral density, prevalence of osteoporosis in native Chinese women.

Authors:  Zhang-Rong Xu; Ai-Hong Wang; Xian-Ping Wu; Hong Zhang; Zhi-Feng Sheng; Xi-Yu Wu; Hui Xie; Xiang-Hang Luo; Er-Yuan Liao
Journal:  Clin Chim Acta       Date:  2008-10-07       Impact factor: 3.786

Review 4.  The amino- and carboxyterminal cross-linked telopeptides of collagen type I, NTX-I and CTX-I: a comparative review.

Authors:  Markus Herrmann; Markus J Seibel; Markus Seibel
Journal:  Clin Chim Acta       Date:  2008-03-27       Impact factor: 3.786

5.  Association of LRP5 gene polymorphism with type 2 diabetes mellitus and osteoporosis in postmenopausal women.

Authors:  Miao Xuan; Yonglan Wang; Wenxing Wang; Jun Yang; Ying Li; Xiuzhen Zhang
Journal:  Int J Clin Exp Med       Date:  2014-01-15

6.  Carboxy-terminal telopeptide (CTX) and amino-terminal propeptide (PINP) of type I collagen as markers of bone metastases in patients with non-small cell lung cancer.

Authors:  Franco Lumachi; Davide A Santeufemia; Alessandro Del Conte; Francesco Mazza; Renato Tozzoli; Giordano B Chiara; Stefano M M Basso
Journal:  Anticancer Res       Date:  2013-06       Impact factor: 2.480

7.  Contribution of serum inflammatory markers to changes in bone mineral content and density in postmenopausal women: a 1-year investigation.

Authors:  E R Gertz; N E Silverman; K S Wise; K B Hanson; D L Alekel; J W Stewart; C D Perry; S N Bhupathiraju; M L Kohut; M D Van Loan
Journal:  J Clin Densitom       Date:  2010 Jul-Sep       Impact factor: 2.617

8.  A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density.

Authors:  G Rannevik; S Jeppsson; O Johnell; B Bjerre; Y Laurell-Borulf; L Svanberg
Journal:  Maturitas       Date:  1995-02       Impact factor: 4.342

9.  Cadmium, follicle-stimulating hormone, and effects on bone in women age 42-60 years, NHANES III.

Authors:  Carolyn M Gallagher; Baljit S Moonga; John S Kovach
Journal:  Environ Res       Date:  2010-01       Impact factor: 6.498

10.  The incidence and characteristics of uterine bleeding during postoperative GnRH agonist treatment combined with estrogen-progestogen add-back therapy in endometriosis patients of reproductive age.

Authors:  Yi Han; Shi-En Zou; Qi-Qi Long; Shao-Fen Zhang
Journal:  Int J Clin Exp Med       Date:  2013-08-01
View more
  2 in total

Review 1.  Actions of pituitary hormones beyond traditional targets.

Authors:  Mone Zaidi; Maria I New; Harry C Blair; Alberta Zallone; Ramkumarie Baliram; Terry F Davies; Christopher Cardozo; James Iqbal; Li Sun; Clifford J Rosen; Tony Yuen
Journal:  J Endocrinol       Date:  2018-03-19       Impact factor: 4.286

2.  FSH, Bone Mass, Body Fat, and Biological Aging.

Authors:  Mone Zaidi; Daria Lizneva; Se-Min Kim; Li Sun; Jameel Iqbal; Maria I New; Clifford J Rosen; Tony Yuen
Journal:  Endocrinology       Date:  2018-10-01       Impact factor: 4.736

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.